rxstatShortages › Esculin Framycetin Dibucaine Hydrocortisone

Esculin Framycetin Dibucaine Hydrocortisone shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Esculin Framycetin Dibucaine Hydrocortisone has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 5
Reports on file
17

Reports by product

Discontinued
TEVA-PROCTOSONE
1% 1% 0.5% 0.5% · OINTMENT · TEVA CANADA LIMITED
DIN 02226383
Resolved
TEVA-PROCTOSONE
5MG 5MG 10MG 10MG · OINTMENT · TEVA CANADA LIMITED
DIN 02226383 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
TEVA-PROCTOSONE
5MG 5MG 10MG 10MG · OINTMENT · TEVA CANADA LIMITED
DIN 02226383 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.
Discontinued
PROCTOSEDYL
1% 1% 0.5% 0.5% · OINTMENT · APTALIS PHARMA CANADA ULC
DIN 02223252
Discontinued
ODAN PROCTOMYXIN HC
1% 1% 0.5% 0.5% · OINTMENT · ODAN LABORATORIES LTD
DIN 02242527
Discontinued
ODAN PROCTOMYXIN HC SUPPOSITORIES
10MG 5MG 10MG 5MG · SUPPOSITORY · ODAN LABORATORIES LTD
DIN 02242528
Resolved
SANDOZ PROCTOMYXIN HC
0.5% 0.5% 1% 1% · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Aug 5, 2021 · Disruption of the manufacture of the drug.
Resolved
SANDOZ PROCTOMYXIN HC
0.5% 0.5% 1% 1% · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Jan 8, 2021 · Delay in shipping of the drug.
Resolved
SANDOZ PROCTOMYXIN HC SUPPOSITORIES
5MG 10MG 5MG 10MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02242528 · ended Oct 16, 2020 · Delay in shipping of the drug.
Resolved
SANDOZ PROCTOMYXIN HC
5MG 5MG 10MG 10MG · OINTMENT · SANDOZ CANADA INCORPORATED
DIN 02242527 · ended Jan 20, 2020 · Demand increase for the drug.
Resolved
SANDOZ PROCTOMYXIN HC SUPPOSITORIES
5MG 5MG 10MG 10MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02242528 · ended Feb 4, 2020 · Demand increase for the drug.
Resolved
PROCTOSEDYL
5MG 10MG 5MG 10MG · OINTMENT · APTALIS PHARMA CANADA ULC
DIN 02223252 · ended Dec 24, 2019 · Disruption of the manufacture of the drug.

Showing 12 of 17 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Esculin Framycetin Dibucaine Hydrocortisone. Health Canada has 17 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Esculin Framycetin Dibucaine Hydrocortisone is classified under “AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE” (ATC C05AA).

Recent changes

Common questions

When will Esculin Framycetin Dibucaine Hydrocortisone be back in stock in Canada?

Esculin Framycetin Dibucaine Hydrocortisone has no active shortage; supply is normal per Health Canada reports.

Why is Esculin Framycetin Dibucaine Hydrocortisone in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (agents for treatment of hemorrhoids and anal fissures for topical use)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.